Table 1.
NSCLC and control patient clinicopathological characteristics
| Characteristic | NSCLC patients | Healthy controls | P |
|---|---|---|---|
| Age | 0.152 | ||
| >60 | 121 (58.7%) | 113 (54.9%) | |
| ≦60 | 85 (41.3%) | 93 (45.1%) | |
| Gender | 0.419 | ||
| Male | 112 (54.4%) | 106 (51.5%) | |
| Female | 94 (45.6%) | 100 (48.5%) | |
| Body mass index, kg/m[2] | 23.12 ± 4.02 | 25.29 ± 5.32 | 0.361 |
| Smoking (%) | 153 (74.3%) | 83 (40.3%) | 0.023 |
| Drinking (%) | 125 (60.7%) | 116 (56.3%) | 0.518 |
| Type of NSCLC (%) | |||
| Adenocarcinoma | 111 (53.9%) | ||
| Squamous cell carcinoma | 95 (46.1%) | ||
| Lymph node metastasis (%) | |||
| Positive | 99 (48.1%) | ||
| Negative | 107 (51.9%) | ||
| TNM stage (%) | |||
| I + II | 109 (52.9%) | ||
| III + IV | 97 (47.1%) | ||
| Tumor differentiation (%) | |||
| Well + moderate | 105 (51.0% | ||
| Poor | 101 (49.0%) |